The first stop for professional medicines advice

Past Events

32 results

Applied filters

Biosimilar and key generic medicines - delivering better value

11 December 2024An overview of NHS England and NHS SPS roles in implementing biosimilar and key generic medicines and what to expect in 2025/26.

Improving Health Outcomes in Health and Justice

3 December 2024Overview of national workstreams, focusing on CGM devices and Structured Medication Reviews. We explored how to use EPS in practice for our FP10s.

Management review and KPIs in pharmacy technical services

20 November 2024An SPS Quality Assurance (QA) bite size learning event on quality management review and key performance indicators (KPIs) in pharmacy technical services.

MSATS - Safe Use of DOACs

30 October 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of DOACs; inspiring partnership across the system.

Dealing with OOS Microbiology Results in Pharmacy Aseptic Units (Part 2)

18 September 2024An SPS Quality Assurance (QA) bite size learning event on managing out of specification microbiological environmental monitoring results in aseptic units.

Implementing ustekinumab biosimilar

4 September 2024This webinar provided information and guidance to support organisations switch to the best value ustekinumab biosimilar

Primary care discussions: Heart failure

20 August 2024A practical discussion between two pharmacists with an interest in heart failure about identifying heart failure and optimising treatment in primary care.

Improving Health Outcomes in Health and Justice

11 July 2024We shared information on the implementation of Continuous Glucose Monitoring Devices in prisons with updates on Methasoft integration and FP10 EPS rollout

Primary care discussions: Population health in practice

2 July 2024Practical application of population health supporting pharmacy professionals undertaking structured medication reviews

Managing complexities of medication use across care boundaries

26 June 2024Exploring the risks for patients on complex or specialist medicines moving across care boundaries with a focus on strategies to reduce harms
admin